Curex, the largest online allergy clinic in the United States, has revealed data indicating that allergy drops, also known as at-home sublingual allergy immunotherapy (SLIT), might offer better results compared to traditional allergy shots.
Allergy shots, also known as subcutaneous immunotherapy (SCIT), are a traditional and effective treatment for allergies. However, they require weekly visits to a doctor's office, which can be inconvenient and time-consuming. SLIT, on the other hand, can be taken at home, making it a more convenient option for many people.
Curex's data indicates patients are more likely to stick with their treatment plan than those undergoing allergy shots. The convenience of at-home administration plays a pivotal role in this trend. It's much simpler to spend two minutes each day on allergy drops as part of your routine than dealing with the hassle of weekly trips to the doctor's office, along with a 30-minute wait after the shot. This makes allergy drops a more attractive option for patients. Following the prescribed treatment plan is linked to better outcomes. In this case, the data suggests a threefold improvement in adherence for those choosing the user-friendly allergy drop treatment.
Doctors prescribe sublingual immunotherapy (SLIT) after conducting patient tests to pinpoint specific allergy triggers, then employ a personalized treatment similar to allergy shots. The safety of self-administering allergy drops at home stems from SLIT's ability to facilitate a gradual increase in allergen dosage, thereby decreasing the risk of side effects and adverse reactions. Severe allergic reactions are extremely rare, occurring only 0.03% of the time.
While SLIT treatment starts at a more gradual pace, the cumulative dosage reaches a comparable level within the initial six months. It is during this time that patients start to report positive improvements, emphasizing the efficacy and safety of the gradual approach of sublingual immunotherapy.
Even more interestingly, the convenience and ease of use enable patients to remain compliant. This means they are having better results. For example, Curex has reported that after one year, over 70% of patients reported a 50% or greater reduction in allergy symptoms and reliance on antihistamines and other allergy medications.
Overall, while allergy shots provide a solution for millions, the introduction of at-home allergy drops has transformed allergy immunotherapy into an accessible solution for a significantly broader demographic. This not only opens doors to a larger population; it also empowers individuals, enabling them to complete treatment and gain lasting relief at a substantially higher rate.
In the realm of allergy immunotherapy, Curex stands as the foremost online health company, pioneering sublingual immunotherapy (SLIT), commonly known as allergy drops. With a widespread presence across all states and a user base exceeding 150,000, Curex has emerged as the go-to solution for accessible and effective long-term allergy relief.
Science Times Verdict
At-home sublingual allergy immunotherapy (SLIT) is a newer treatment for allergies that is gaining popularity. Curex's data suggests that SLIT allergy drops may be more convenient and effective than traditional allergy shots, but more research is needed to confirm these findings.
If you are considering SLIT, it is important to talk to your doctor to see if it is the right treatment for you.
* This is a contributed article and this content does not necessarily represent the views of sciencetimes.com
![Apple Is Developing Homegrown Chips to Run AI Tools in Data Centers [Report]](https://1721181113.rsc.cdn77.org/data/thumbs/full/53497/89/56/50/40/apple-is-developing-homegrown-chips-to-run-ai-tools-in-data-centers-report.jpeg)
